13F Filings History of GREAT POINT PARTNERS LLC

Latest 13F report
Q4 2025 - 17 Feb 2026
Value $
$308,414,328
Notable people
Mr. David Kroin, Ortav Yehudai, Lillian Nordahl
Signature - Title
Dr. Jeffrey R. Jay, M.D. - Senior Managing Member
Location
Greenwich, CT
Summary
This page shows a list of all the recent 13F filings made by GREAT POINT PARTNERS LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. GREAT POINT PARTNERS LLC reported 29 stock holdings with total value $308,414,328 as of Q4 2025. Top holdings included APGE, AMLX, ZURA, IRON, and RAPT.

Notify me when GREAT POINT PARTNERS LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 29 $308,414,328 +$143,339,046 -$81,469,179 +$61,869,867 APGE, AMLX, ZURA, IRON, RAPT 13F-HR 17 Feb 2026, 16:08
Q3 2025 28 $239,520,840 +$96,939,529 -$173,164,255 -$76,224,726 AMLX, RZLT, NKTR, ZURA, SLNO 13F-HR 14 Nov 2025, 11:49
Q2 2025 26 $153,801,796 +$56,641,300 -$101,478,949 -$44,837,649 IONS, RZLT, AMLX, LEGN, ABVX 13F-HR 14 Aug 2025, 16:15
Q1 2025 31 $183,973,769 +$53,297,480 -$38,718,197 +$14,579,283 CYTK, KALV, EOLS, ABVX, VRDN 13F-HR 15 May 2025, 16:10
Q4 2024 26 $212,199,809 +$41,418,205 -$102,967,171 -$61,548,966 IONS, CYTK, KALV, VRDN, PLRX 13F-HR 14 Feb 2025, 16:13
Q3 2024 29 $331,410,559 +$32,570,018 -$227,355,322 -$194,785,304 NGNE, ABVX, PLRX, EOLS, VRDN 13F-HR 13 Nov 2024, 16:16
Q2 2024 33 $522,016,114 +$170,044,820 -$249,939,479 -$79,894,659 URGN, NGNE, ABVX, MRUS, PLRX 13F-HR 14 Aug 2024, 16:38
Q1 2024 35 $641,637,881 +$222,251,387 -$293,899,773 -$71,648,386 NGNE, ALPN, URGN, ABVX, EOLS 13F-HR 15 May 2024, 16:24
Q4 2023 34 $586,726,411 +$114,195,081 -$189,141,338 -$74,946,257 ALPN, CYTK, URGN, PLRX, RARE 13F-HR 14 Feb 2024, 16:07
Q3 2023 39 $531,602,489 +$165,234,328 -$92,413,058 +$72,821,270 URGN, ALPN, PLRX, PCVX, RARE 13F-HR 14 Nov 2023, 16:16
Q2 2023 36 $499,223,928 +$135,081,465 -$147,003,304 -$11,921,839 ALPN, RARE, PCVX, PLRX, RAPT 13F-HR 14 Aug 2023, 16:17
Q1 2023 42 $505,967,073 +$180,872,324 -$150,491,950 +$30,380,374 PLRX, XENE, ALPN, RARE, RAPT 13F-HR 15 May 2023, 16:09
Q4 2022 40 $483,681,723 +$218,587,663 -$127,179,273 +$91,408,390 PCVX, XENE, RAPT, ALPN, PLRX 13F-HR 14 Feb 2023, 16:02
Q3 2022 40 $406,202,118 +$145,503,060 -$166,316,107 -$20,813,047 XENE, JAZZ, PNT, ALPN, TVTX 13F-HR 14 Nov 2022, 16:24
Q2 2022 33 $376,877,275 +$128,178,692 -$122,276,262 +$5,902,430 XENE, JAZZ, CYTK, TVTX, PCVX 13F-HR 15 Aug 2022, 16:25
Q1 2022 29 $413,242,000 +$137,128,331 -$158,595,309 -$21,466,978 EXEL, XENE, TVTX, BCYC, JAZZ 13F-HR 16 May 2022, 16:24
Q4 2021 35 $447,367,000 +$170,610,787 -$150,649,986 +$19,960,801 ARNA, EXEL, XENE, TVTX, ANAB 13F-HR 14 Feb 2022, 11:22
Q3 2021 35 $422,880,000 +$155,126,905 -$173,039,983 -$17,913,078 EXEL, ARNA, KDMN, BCAB, RCKT 13F-HR 15 Nov 2021, 16:36
Q2 2021 28 $447,211,000 +$139,590,097 -$146,460,856 -$6,870,759 MGNX, RCKT, ARNA, UTHR, PODD 13F-HR 16 Aug 2021, 16:33
Q1 2021 28 $483,855,000 +$164,991,284 -$240,886,976 -$75,895,692 MGNX, RCKT, IOVA, SAGE, XENT 13F-HR 17 May 2021, 16:05
Q4 2020 31 $607,037,000 +$172,475,216 -$883,745,776 -$711,270,560 GWPH, IOVA, SAGE, ACAD, RCKT 13F-HR 16 Feb 2021, 16:17
Q3 2020 33 $1,106,166,000 +$174,494,061 -$336,217,042 -$161,722,981 IOVA, SAGE, ACAD, ARNA, ZYME 13F-HR 16 Nov 2020, 16:41
Q2 2020 35 $1,244,184,000 +$476,455,187 -$244,347,277 +$232,107,910 CNST, IOVA, ZYME, ACAD, SAGE 13F-HR 14 Aug 2020, 16:55
Q1 2020 32 $885,655,000 +$247,591,743 -$329,702,317 -$82,110,574 ACAD, ZYME, PTCT, IOVA, CNST 13F-HR 15 May 2020, 16:04
Q4 2019 34 $1,040,006,000 +$385,584,082 -$541,497,646 -$155,913,564 IOVA, ZYME, PTCT, NXTC, TGTX 13F-HR 14 Feb 2020, 16:17
Q3 2019 34 $945,409,000 +$340,093,616 -$75,426,843 +$264,666,773 IOVA, ZGNX, ACAD, BOLD, PTCT 13F-HR 15 Nov 2019, 14:01
Q2 2019 25 $823,885,000 +$236,465,686 -$356,166,809 -$119,701,123 IOVA, PTCT, ZGNX, BOLD, KURA 13F-HR 14 Aug 2019, 16:05
Q1 2019 31 $903,051,000 +$180,919,636 -$175,751,442 +$5,168,194 PTCT, ZGNX, GBT, BOLD, ACAD 13F-HR 14 May 2019, 16:05
Q4 2018 34 $720,071,000 +$350,306,684 -$123,805,315 +$226,501,369 BCRX, IOVA, GBT, XLRN, ACAD 13F-HR 14 Feb 2019, 21:01
Q3 2018 29 $637,326,000 +$179,911,398 -$207,573,819 -$27,662,421 BCRX, XLRN, ZFGN, IOVA, UTHR 13F-HR 14 Nov 2018, 16:00
Q2 2018 31 $633,390,000 +$206,475,188 -$234,006,420 -$27,531,232 PTCT, KURA, IOVA, BCRX, ONCE 13F-HR 14 Aug 2018, 16:00
Q1 2018 30 $640,277,000 +$212,824,215 -$182,874,895 +$29,949,320 IOVA, ARNA, KURA, PTCT, ZGNX 13F-HR 14 May 2018, 16:00
Q4 2017 37 $573,906,000 +$222,362,251 -$115,758,754 +$106,603,497 ZGNX, ARNA, KURA, SAGE, GBT 13F-HR 14 Feb 2018, 16:10
Q3 2017 31 $405,215,000 +$77,408,713 -$289,727,994 -$212,319,281 ZGNX, ARNA, CNCE, NBIX, FOMX 13F-HR 14 Nov 2017, 16:02
Q2 2017 32 $519,960,000 +$153,531,913 -$106,438,005 +$47,093,908 ARNA, ADMS, VNDA, ZGNX, PTCT 13F-HR 14 Aug 2017, 16:12
Q1 2017 32 $456,680,000 +$157,552,500 -$175,649,578 -$18,097,078 ADMS, CNCE, SGYPQ, VNDA, RIGL 13F-HR 15 May 2017, 16:00
Q4 2016 31 $453,514,000 +$129,169,894 -$45,938,908 +$83,230,986 ADMS, FOMX, VNDA, SGYPQ, ZGNX 13F-HR 14 Feb 2017, 16:06
Q3 2016 30 $383,234,000 +$108,245,607 -$133,400,723 -$25,155,116 VNDA, ADMS, SGYPQ, ZGNX, FOMX 13F-HR 14 Nov 2016, 17:31
Q2 2016 37 $341,183,000 +$127,010,248 -$66,856,511 +$60,153,737 ADMS, VNDA, SGYPQ, EXEL, DERM 13F-HR 15 Aug 2016, 16:08
Q1 2016 30 $262,295,000 +$95,287,987 -$2,807,182 +$92,480,805 ADMS, FPRX, VNDA, ZGNX, TTPH 13F-HR 16 May 2016, 15:02
Q4 2015 21 $228,003,000 +$37,020,953 -$78,792,840 -$41,771,887 ADMS, FPRX, ZGNX, VNDA, TTPH 13F-HR 16 Feb 2016, 13:21
Q3 2015 32 $232,359,000 +$89,220,089 -$29,797,164 +$59,422,925 VNDA, FPRX, CNXR, ADMS, ZGNX 13F-HR 16 Nov 2015, 10:58
Q2 2015 31 $252,626,000 +$103,235,370 -$82,083,905 +$21,151,465 CNXR, ADMS, VNDA, FPRX, SGYPQ 13F-HR 14 Aug 2015, 13:11
Q1 2015 30 $221,364,000 +$76,090,609 -$85,569,403 -$9,478,794 CNXR, HPTX, VNDA, OFIX, ADMS 13F-HR 15 May 2015, 11:49
Q4 2014 27 $206,730,000 +$85,514,946 -$110,545,696 -$25,030,750 CNXR, HPTX, ALIM, OCRX, DSCI 13F-HR 17 Feb 2015, 09:19
Q3 2014 34 $221,884,000 +$82,091,933 -$65,735,715 +$16,356,218 HPTX, NBIX, INFI, ALIM, OPHT 13F-HR 14 Nov 2014, 10:26
Q2 2014 36 $219,179,000 +$91,965,243 -$41,966,202 +$49,999,041 NBIX, HPTX, DSCI, THOR, INFI 13F-HR 14 Aug 2014, 16:17
Q1 2014 33 $179,843,000 +$82,553,868 -$54,402,827 +$28,151,041 FURX, HPTX, PTIE, ALIM, DSCI 13F-HR 15 May 2014, 16:30
Q4 2013 26 $136,476,000 $0 $0 $0 HPTX, PTIE, FURX, SSH, AMBI 13F-HR 14 Feb 2014, 06:17